PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

145 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Neschen, S. et al.: Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice. Diabetes 64, 284-290 (2015)
Ott, V.* et al.: Central nervous insulin administration does not potentiate the acute glucoregulatory impact of concurrent mild hyperinsulinemia. Diabetes 64, 760-765 (2015)
Papandonatos, G.D.* et al.: Genetic predisposition to weight loss and regain with lifestyle intervention: Analyses from the Diabetes Prevention Program and the Look AHEAD randomized controlled trials. Diabetes 64, 4312-4321 (2015)
Qi, Q.* et al.: Dietary intake, FTO genetic variants and adiposity: A combined analysis of over 16,000 children and adolescents. Diabetes 64, 2467-2476 (2015)
Segrè, A.V.* ; Wei, N.* & DIAGRAM Consortium (Florez, J.C* ; Klopp, N. ; Illig, T. ; Müller-Nurasyid, M. ; Peters, A.): Pathways targeted by antidiabetes drugs are enriched for multiple genes associated with type 2 diabetes risk. Diabetes 64, 1470-1483 (2015)
Sweetwyne, M.T.* et al.: Notch1 and Notch2 in podocytes play differential roles during diabetic nephropathy development. Diabetes 64, 4099-4111 (2015)
Törn, C.* et al.: Role of Type 1 diabetes associated SNPs on risk of autoantibody positivity in the TEDDY study. Diabetes 64, 1818-1829 (2015)
Wiedemann, T. ; Bielohuby, M.* ; Müller, T.D. ; Bidlingmaier, M.* & Pellegata, N.S.: Obesity in MENX rats is accompanied by high circulating levels of ghrelin and improved insulin sensitivity. Diabetes 65, 406-420 (2015)
Williams, A.J.* et al.: Detection of antibodies directed to the N-terminal region of GAD is dependent on assay format and contributes to differences in the specificity of GAD autoantibody assays for type 1 diabetes. Diabetes 64, 3239-3246 (2015)
Williams, A.J.* et al.: Reactivity to N-terminally truncated GAD65(96-585) identifies GAD autoantibodies that are more closely associated with diabetes progression in relatives of patients with type 1 diabetes. Diabetes 64, 3247-3252 (2015)
Clemmensen, C. et al.: GLP-1/glucagon co-agonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet. Diabetes 63, 1422-1427 (2014)
Endesfelder, D. et al.: Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63, 2006-2014 (2014)
Ferreira, R.C.* et al.: A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk of type 1 diabetes. Diabetes 63, 2538-2550 (2014)
Habegger, K.M.* et al.: GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats. Diabetes 63, 505-513 (2014)
Heni, M. et al.: Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 63, 4083-4088 (2014)
Heppner, K.M.* et al.: Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via CNS ghrelin receptors. Diabetes 63, 122-131 (2014)
Herder, C.* et al.: Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits. Diabetes 63, 4343-4359 (2014)
Keildson, S.* et al.: Expression of phosphofructokinase in skeletal muscle is influenced by genetic variation and associated with insulin sensitivity. Diabetes 63, 1154-1165 (2014)
Tong, J.* et al.: Acute administration of unacylated ghrelin has no effect on basal or stimulated insulin secretion in healthy humans. Diabetes 63, 2309-2319 (2014)
Dimas, A.S.* et al.: Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63, 2158-2171 (2013)